CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018	[1]
Current assets:
Cash and cash equivalents	$ 65,151	$ 62,417
Short-term marketable securities	127,027	52,491
Related party receivables from collaborative arrangements	58,639	83,286
Prepaid expenses and other current assets	702	849
Total current assets	251,519	199,043
Property and equipment, net	148	160
Operating lease right-of-use asset	1,421	0
Capitalized fees paid to a related party, net	149,443	152,899
Deferred tax assets	187,546	196,054
Other assets	37	37
Total assets	590,114	548,193
Current liabilities:
Accounts payable	144	11
Accrued personnel-related expenses	325	470
Accrued interest payable	1,775	4,264
Other accrued liabilities	1,258	955
Operating lease liability, current portion	308	0
Total current liabilities	3,810	5,700
Long-term debt, net of discount and issuance costs	384,744	382,855
Operating lease liability, net of current portion	1,238	0
Other long-term liabilities	379	586
Commitments and contingencies
Stockholders' equity
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding	0	0
Common stock: $0.01 par value, 200,000 shares authorized, 101,183 and 101,098 issued and outstanding as of March 31, 2019 and December 31, 2018, respectively	1,012	1,011
Additional paid-in capital	1,257,125	1,256,267
Accumulated other comprehensive income (loss)	10	(3)
Accumulated deficit	(1,069,902)	(1,103,692)
Total Innoviva stockholders' equity	188,245	153,583
Noncontrolling interest	11,698	5,469
Total stockholders' equity	199,943	159,052
Total liabilities and stockholders' equity	$ 590,114	$ 548,193

[1] Condensed consolidated balance sheet as of December 31, 2018 has been derived from audited consolidated financial statements.